Comparable stake leader
Soleus Capital Master Fund, L.P.
SEC ownership of NovoCure Ltd
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001645113.
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- NVCR on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Soleus Capital Master Fund, L.P.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Soleus Capital Master Fund, L.P.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001645113
- Issuer location
- St. Helier
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of NovoCure Ltd (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Soleus Capital Master Fun...
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.1%
13D/G row: Soleus Capital Master Fund, L.P.
Showing 1-8 of 50 holder rows.
Quick read
Soleus Capital Master Fund, L.P. leads the comparable SEC ownership view at 9.1%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Soleus Capital Master Fund, L.P.'s linked filing trail.
Comparable ownership
Top 5
Soleus Capital Master Fund, L.P.
9.1%
BlackRock, Inc.
8.3%
VANGUARD PORTFOLIO MANAGEMENT LLC
5.6%
Capital World Investors
1.8%
Asaf Danziger
0.36%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. |
13D/G
|
9.1%
|
$110,694,725
10,492,391 shares
|
+$20,696,209 | 31 Mar 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
8.3%
|
$168,501,151
9,083,620 shares
|
$0 | 31 Mar 2025 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
Vanguard Portfolio Management · Company
|
5.6%
|
$69,105,935
6,339,994 shares
|
$0 | 31 Mar 2026 |
| Capital World Investors |
13D/G
|
1.8%
|
$25,840,000
2,000,000 shares
|
-$56,626,396 | 30 Sep 2025 |
| Asaf Danziger |
3/4/5
Director
|
0.36%
|
$4,542,487
416,742 shares
|
— | 30 Jun 2026 |
| FMR LLC |
13F
Company
|
15%
|
$186,053,728
17,069,149 shares
|
— | 31 Mar 2026 |
| Soleus Capital Management, L.P. |
13F
Company
|
9.1%
|
$114,367,062
10,492,391 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
4.1%
|
$51,034,498
4,682,064 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$2,023,640.
Buys
$1,228,659
Insiders: 2
Sells
$3,252,299
Insiders: 14
Net
-$2,023,640
Shares: -126,611
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 101,550
Shares: 228,161
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 54,888 | $0 | $939,748 | -$939,748 |
| 3-6 | 0 | 173,273 | $0 | $2,312,551 | -$2,312,551 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 101,550 | 0 | $1,228,659 | $0 | +$1,228,659 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 25 reporting-owner rows connected to NovoCure Ltd. Open a relationship link for the CIK-to-CIK filing trail.
Rows
25
Largest Forms 3/4/5 holder
Ashley Cordova
Net 12M change
-$2,023,641
Latest report
30 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ashley Cordova | Former Chief Executive Officer | $9,371,599 | +$996,859 | +12% | Mixed | 04 Mar 2026 |
| Frank X. Leonard | Chief Executive Officer | $6,511,999 | -$919,823 | -12% | Mixed | 30 Jun 2026 |
| Wilhelmus Cm Groenhuysen | Chief Operating Officer | $5,255,930 | Mixed | 28 Jun 2024 | ||
| Uri Weinberg | Chf Medical and Innovation Ofr | $5,037,536 | -$232,178 | -4.4% | Mixed | 03 Mar 2026 |
| Asaf Danziger | Director | $4,542,487 | Median | 30 Jun 2026 | ||
| William F. Doyle | Executive Chairman, Director | $4,409,977 | -$932,883 | -17% | Filing P/S | 03 Mar 2026 |
| Barak Ben Arye | General Counsel | $4,139,363 | Mixed | 30 Jun 2026 | ||
| Christoph Brackmann | Chief Financial Officer | $3,915,252 | +$146,486 | +3.9% | Mixed | 03 Mar 2026 |
| Michal Nath Puri | Chief Human Resources Officer | $3,697,641 | -$34,325 | -0.92% | Mixed | 30 Jun 2026 |
| Nicolas Leupin | Former Chief Medical Officer | $2,852,643 | -$28,696 | -1% | Mixed | 04 Mar 2026 |
| Mukund Paravasthu | Chief Operating Officer | $2,485,654 | -$693,966 | -22% | Mixed | 03 Mar 2026 |
| Moshe Giladi | Chief Science Officer | $2,411,503 | Mixed | 27 Feb 2024 | ||
| W. Anthony Vernon | Director | $2,382,543 | -$46,445 | -1.9% | Mixed | 03 Jun 2026 |
| Shah Pritesh | Chief Growth Officer | $1,575,064 | Filing P/S | 07 Nov 2023 | ||
| Gabriel Leung | Director | $1,203,621 | -$46,445 | -3.7% | Mixed | 03 Jun 2026 |
| Todd Christopher Longsworth | General Counsel | $860,119 | Mixed | 08 Mar 2022 | ||
| William Patrick Burke | Chief Human Resources Officer | $840,555 | Mixed | 30 Jun 2023 | ||
| David Hung | Director | $451,150 | -$46,445 | -9.3% | Mixed | 03 Jun 2026 |
| Martin J. Madden | Director | $431,628 | Mixed | 03 Jun 2026 | ||
| Timothy J. Scannell | Director | $383,821 | -$46,445 | -11% | Mixed | 03 Jun 2026 |
Recent insider transactions for NovoCure Ltd
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michal Nath Puri | NVCR | Ordinary Shares | Award | 0.95% | 1,905 | 203,227 | 30 Jun 2026 | Direct | ||
| Frank X. Leonard | NVCR | Ordinary Shares | Award | 0.41% | 1,905 | 461,425 | 30 Jun 2026 | Direct | ||
| Barak Ben Arye | NVCR | Ordinary Shares | Award | 0.54% | 1,299 | 243,752 | 30 Jun 2026 | Direct | ||
| Asaf Danziger | NVCR | Ordinary Shares | Award | 0.06% | 268 | 416,742 | 30 Jun 2026 | Direct | ||
| Frank X. Leonard | NVCR | Ordinary Shares | Sale | -6.94% | $614,635 | $17.93 | -34,273 | 459,520 | 04 Jun 2026 | Direct |
| Gabriel Leung | NVCR | Ordinary Shares | Award | 13% | 11,610 | 101,109 | 03 Jun 2026 | Direct | ||
| Gabriel Leung | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| Kristin Stafford | NVCR | Ordinary Shares | Award | 102.5% | 11,610 | 22,934 | 03 Jun 2026 | Direct | ||
| Kristin Stafford | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| Allyson J. Ocean | NVCR | Ordinary Shares | Award | 102.5% | 11,610 | 22,934 | 03 Jun 2026 | Direct | ||
| Allyson J. Ocean | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| Timothy J. Scannell | NVCR | Ordinary Shares | Award | 81.3% | 11,610 | 25,898 | 03 Jun 2026 | Direct | ||
| Timothy J. Scannell | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| Jeryl L. Hilleman | NVCR | Ordinary Shares | Award | 83.8% | 11,610 | 25,471 | 03 Jun 2026 | Direct | ||
| Jeryl L. Hilleman | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| David Hung | NVCR | Ordinary Shares | Award | 56.7% | 11,610 | 32,075 | 03 Jun 2026 | Direct | ||
| David Hung | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| Martin J. Madden | NVCR | Ordinary Shares | Award | 62.2% | 11,610 | 30,284 | 03 Jun 2026 | Direct | ||
| Martin J. Madden | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| W. Anthony Vernon | NVCR | Ordinary Shares | Award | 5.87% | 11,610 | 209,267 | 03 Jun 2026 | Direct | ||
| W. Anthony Vernon | NVCR | Stock Option (Right to Buy) | Award | 16,999 | 16,999 | 03 Jun 2026 | Direct | |||
| Gabriel Leung | NVCR | Ordinary Shares | Sale | -3.19% | $46,445 | $15.77 | -2,945 | 89,499 | 02 Jun 2026 | Direct |
| Kristin Stafford | NVCR | Ordinary Shares | Sale | -20.6% | $46,445 | $15.77 | -2,945 | 11,324 | 02 Jun 2026 | Direct |
| Allyson J. Ocean | NVCR | Ordinary Shares | Sale | -20.6% | $46,445 | $15.77 | -2,945 | 11,324 | 02 Jun 2026 | Direct |
| Timothy J. Scannell | NVCR | Ordinary Shares | Sale | -17.1% | $46,445 | $15.77 | -2,945 | 14,288 | 02 Jun 2026 | Direct |
| Jeryl L. Hilleman | NVCR | Ordinary Shares | Sale | -17.5% | $46,445 | $15.77 | -2,945 | 13,861 | 02 Jun 2026 | Direct |
| W. Anthony Vernon | NVCR | Ordinary Shares | Sale | -1.47% | $46,445 | $15.77 | -2,945 | 197,657 | 02 Jun 2026 | Direct |
| David Hung | NVCR | Ordinary Shares | Sale | -12.6% | $46,445 | $15.77 | -2,945 | 20,465 | 02 Jun 2026 | Direct |
| W. Anthony Vernon | NVCR | Ordinary Shares | Options Exercise | 12% | 21,500 | 200,602 | 28 Apr 2026 | Direct | ||
| W. Anthony Vernon | NVCR | Stock Option (Right to Buy) | Options Exercise | -100% | -21,500 | 0 | 28 Apr 2026 | Direct | ||
| Mukund Paravasthu | NVCR | Ordinary Shares | Sale | -37.3% | $595,670 | $13.77 | -43,246 | 72,832 | 05 Mar 2026 | Direct |
| Nicolas Leupin | NVCR | Ordinary Shares | Sale | -1.06% | $14,636 | $13.31 | -1,100 | 102,979 | 04 Mar 2026 | Direct |
| Ashley Cordova | NVCR | Ordinary Shares | Tax liability | -4.01% | -17,638 | 422,570 | 04 Mar 2026 | Direct | ||
| Uri Weinberg | NVCR | Ordinary Shares | Sale | -2.34% | $85,314 | $13.31 | -6,412 | 267,190 | 04 Mar 2026 | Direct |
| Christoph Brackmann | NVCR | Ordinary Shares | Sale | -3.39% | $85,314 | $13.31 | -6,412 | 182,842 | 04 Mar 2026 | Direct |
| Frank X. Leonard | NVCR | Ordinary Shares | Sale | -1.12% | $74,603 | $13.31 | -5,607 | 493,793 | 04 Mar 2026 | Direct |
| Mukund Paravasthu | NVCR | Ordinary Shares | Sale | -4.43% | $71,543 | $13.31 | -5,377 | 116,078 | 04 Mar 2026 | Direct |
| Michal Nath Puri | NVCR | Ordinary Shares | Sale | -0.54% | $14,636 | $13.31 | -1,100 | 201,322 | 04 Mar 2026 | Direct |
| Barak Ben Arye | NVCR | Ordinary Shares | Award | 26.1% | 50,125 | 242,453 | 03 Mar 2026 | Direct | ||
| Barak Ben Arye | NVCR | Stock Option (Right to Buy) | Award | 73,340 | 73,340 | 03 Mar 2026 | Direct | |||
| Uri Weinberg | NVCR | Ordinary Shares | Award | 22.4% | 50,125 | 273,602 | 03 Mar 2026 | Direct | ||
| Uri Weinberg | NVCR | Stock Option (Right to Buy) | Award | 73,340 | 73,340 | 03 Mar 2026 | Direct | |||
| Christoph Brackmann | NVCR | Ordinary Shares | Award | 41.1% | 55,137 | 189,254 | 03 Mar 2026 | Direct | ||
| Christoph Brackmann | NVCR | Stock Option (Right to Buy) | Award | 80,674 | 80,674 | 03 Mar 2026 | Direct | |||
| Frank X. Leonard | NVCR | Ordinary Shares | Award | 42.9% | 150,000 | 499,400 | 03 Mar 2026 | Direct | ||
| Frank X. Leonard | NVCR | Stock Option (Right to Buy) | Award | 216,388 | 216,388 | 03 Mar 2026 | Direct | |||
| Mukund Paravasthu | NVCR | Ordinary Shares | Award | 59.1% | 45,112 | 121,455 | 03 Mar 2026 | Direct | ||
| Mukund Paravasthu | NVCR | Stock Option (Right to Buy) | Award | 66,006 | 66,006 | 03 Mar 2026 | Direct | |||
| Michal Nath Puri | NVCR | Ordinary Shares | Award | 24.7% | 40,100 | 202,422 | 03 Mar 2026 | Direct | ||
| Michal Nath Puri | NVCR | Stock Option (Right to Buy) | Award | 58,672 | 58,672 | 03 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.